Compare Salesforce Inc (CRM) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Salesforce Inc vs Tenet Healthcare Corporation — how do they compare? Salesforce Inc trades at $227.71 (market cap $184.81B), while Tenet Healthcare Corporation trades at $260 (market cap $20.92B). The key difference: Salesforce Inc is far larger — about 8.8× Tenet Healthcare Corporation's market cap, and Salesforce Inc pays a 0.78% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Salesforce Inc for 89 Days and Tenet Healthcare Corporation for 15 Days on average.
| CRM | THC | |
|---|---|---|
Market Cap | $184.81B | $20.92B |
Volume | 5,173,995 | 455,764 |
Sector | Technology | Health |
52-Week High | $266.23 | $280.77 |
52-Week Low | $150.12 | $161.37 |
Typical Hold Time | 89 Days | 15 Days |
Enterprise Value | $215.15B | $32.00B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Salesforce (CRM) trades at $227.80, up 1.25% with a bearish technical signal despite strong fundamentals. The company reported robust earnings beats in recent quarters with Q2 2026 EPS of $5.90 versus $3.27 expected. Revenue grew to $37.90B in 2025 with impressive 77.28% gross margins and 21.99% net income margin. Analyst consensus remains strongly bullish with 76.5% buy ratings and $271.91 price target, representing 19% upside potential.
The stock presents a compelling value opportunity with reasonable P/E of 20.56 and strong profitability metrics, though technical indicators signal near-term weakness. Key risks include AI-driven software sector volatility and macroeconomic headwinds affecting enterprise spending. Current levels offer attractive entry for long-term investors given the company's dominant market position and consistent execution.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with strong technical momentum and bullish moving average signals. The company demonstrates robust fundamentals with consistent earnings beats (Q4 2025-Q2 2026), 82.83% gross margins, and 53.31% ROE. Recent news highlights strong cash flow supporting capital returns, with Q3 2026 results expected October 29, 2026.
THC presents compelling value with a 10.04 P/E ratio and 81.25% analyst buy ratings. Upside potential to $283.36 consensus target exists, though negative cash flow trends and insider selling warrant monitoring. The stock's premium valuation (P/B 4.49) requires sustained execution amid healthcare sector volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Salesforce Inc
Salesforce Inc provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group to deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.
Read more on CRM →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
